BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 10578046)

  • 41. Site-specific core 1 O-glycosylation pattern of the porcine submaxillary gland mucin tandem repeat. Evidence for the modulation of glycan length by peptide sequence.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1998 Oct; 273(41):26580-8. PubMed ID: 9756896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
    Bennett EP; Hassan H; Mandel U; Mirgorodskaya E; Roepstorff P; Burchell J; Taylor-Papadimitriou J; Hollingsworth MA; Merkx G; van Kessel AG; Eiberg H; Steffensen R; Clausen H
    J Biol Chem; 1998 Nov; 273(46):30472-81. PubMed ID: 9804815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat. Further evidence for the modulation of O-glycans side chain structures by peptide sequence.
    Gerken TA; Gilmore M; Zhang J
    J Biol Chem; 2002 Mar; 277(10):7736-51. PubMed ID: 11777921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
    Gerken TA; Zhang J; Levine J; Elhammer A
    J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired O-Glycosylation at Consecutive Threonine TTX Motifs in Mucins Generates Conformationally Restricted Cancer Neoepitopes.
    Hayakawa S; Matsushita T; Yokoi Y; Wakui H; Garcia-Martin F; Hinou H; Matsuoka K; Nouso K; Kamiyama T; Taketomi A; Nishimura SI
    Biochemistry; 2020 Mar; 59(12):1221-1241. PubMed ID: 32155332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.
    Vavasseur F; Dole K; Yang J; Matta KL; Myerscough N; Corfield A; Paraskeva C; Brockhausen I
    Eur J Biochem; 1994 Jun; 222(2):415-24. PubMed ID: 8020479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
    Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
    J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycosylations versus conformational preferences of cancer associated mucin core.
    Schuman J; Qiu D; Koganty RR; Longenecker BM; Campbell AP
    Glycoconj J; 2000 Dec; 17(12):835-48. PubMed ID: 11511808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines.
    Tamada Y; Iida S; Aoki D; Nozawa S; Irimura T
    Oncol Res; 1999; 11(5):233-41. PubMed ID: 10608618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
    Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
    Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Engineering mammalian mucin-type O-glycosylation in plants.
    Yang Z; Drew DP; Jørgensen B; Mandel U; Bach SS; Ulvskov P; Levery SB; Bennett EP; Clausen H; Petersen BL
    J Biol Chem; 2012 Apr; 287(15):11911-23. PubMed ID: 22334671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
    Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
    J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation.
    Müller S; Hanisch FG
    J Biol Chem; 2002 Jul; 277(29):26103-12. PubMed ID: 12000758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation.
    Cao Y; Schlag PM; Karsten U
    Virchows Arch; 1997 Sep; 431(3):159-66. PubMed ID: 9334836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
    Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
    J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes.
    Beum PV; Singh J; Burdick M; Hollingsworth MA; Cheng PW
    J Biol Chem; 1999 Aug; 274(35):24641-8. PubMed ID: 10455130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
    Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
    BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans.
    Cao Y; Karsten U
    Histochem Cell Biol; 2001 Apr; 115(4):349-56. PubMed ID: 11405064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.
    Zhang Y; Iwasaki H; Wang H; Kudo T; Kalka TB; Hennet T; Kubota T; Cheng L; Inaba N; Gotoh M; Togayachi A; Guo J; Hisatomi H; Nakajima K; Nishihara S; Nakamura M; Marth JD; Narimatsu H
    J Biol Chem; 2003 Jan; 278(1):573-84. PubMed ID: 12407114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.